<DOC>
	<DOCNO>NCT02757417</DOCNO>
	<brief_summary>To determine safety profile sodium fluorescein woman undergo cystoscopy gynecologic surgery . To determine either oral phenazopyridine sodium fluorescein result shorter cystoscopy time .</brief_summary>
	<brief_title>Intravenous Sodium Fluorescein Versus Oral Phenazopyridine Ureteral Patency</brief_title>
	<detailed_description />
	<criteria>Patients must 18 year old well willing able provide inform consent Patients undergo schedule gynecologic procedure cystoscopy Patients young 18 year Patients unable unwilling provide inform consent Patients history allergic reaction sodium fluorescein phenazopyridine Patients history renal insufficiency Patients history liver disease Patients history sickle cell disease Patients history glucose6phosphate dehydrogenase deficiency Patients history chronic obstructive pulmonary disease currently treat asthma</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>